H:/rec/ntenvven/NRP1/DCC/REC/5 %5 OC-24/ 2 Abstract The invention relates to polymorphic crystal modifications of 1-[(4-methylquinazolin-2 yl)niethyl]-3 -methyl-7-(2-butvn-1 -yl)-8-( 3 -(R)-amino-piperi din-1 -yl)-xanthine, their production and their use for the preparation of a drug.
申请公布号
AU2013248220(A1)
申请公布日期
2013.11.14
申请号
AU20130248220
申请日期
2013.10.24
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
发明人
KEMMER, DIRK;RENZ, MARTIN;NICOLA, THOMAS;SIEGER, PETER;KOHLBAUER, PETER
